Center For Neurologic Study is located in La Jolla, CA. The organization was established in 1990. According to its NTEE Classification (G96) the organization is classified as: Neurology & Neuroscience, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 06/2021, Center For Neurologic Study employed 4 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Center For Neurologic Study is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2021, Center For Neurologic Study generated $2.0m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 6 years, the organization has seen revenues fall by an average of (38.3%) each year. All expenses for the organization totaled $531.2k during the year ending 06/2021. As we would expect to see with falling revenues, expenses have declined by (40.5%) per year over the past 6 years. You can explore the organizations financials more deeply in the financial statements section below.
Since 2017, Center For Neurologic Study has awarded 12 individual grants totaling $715,179. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
TO ADVANCE THE CAUSE OF PATIENTS WITH DISORDERS OF THE NERVOUS SYSTEM.
Describe the Organization's Program Activity:
Part 3 - Line 4a
RESEARCH: WORK UNDERTAKEN AT CNS PLAYED A ROLE IN THE INTRODUCTION OF INTERFERON FOR THE TREATMENT OF MULTIPLE SCLEROSIS. THE CENTER PARTICIPATED IN NUMEROUS NATIONAL, EXPERIMENTAL TREATMENT TRIALS INVOLVING AMYOTROPHIC LATERAL SCLEROSIS, ALZHEIMER'S DISEASE, NEUROPATHY WHICH LED TO THE DISCOVERY OF NUEDEXTA WHICH HAS BEEN APPROVED FOR USE IN THE UNITED STATES AND EUROPE. REMARKABLY, THE DRUG HAS IMPROVED FUNCTION IN BOTH ALZHEIMER'S DISEASE AND ALS PATIENTS, WITH STUDY RESULTS PUBLISHED IN MAJOR SCIENTIFIC JOURNALS. PIONEERING WORK DONE AT CNS IN COLLABORATION WITH THE UNIVERSITY OF CALIFORNIA AND IONIS PHARMACEUTICALS IS WIDELY BELIVED TO BE THE MOST PROMISING STRATEGY FOR TREATING NEURODEGENERATIVE DISEASES SUCH AS HUNTINGTON'S DISEASE AND FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS. THIS STRATEGY INVOLVES THE SYNTHESIS OF SMALL MOLECULES THAT DOWN REGULATE THE EXPRESSION OF MUTANT PROTEINS IN THE BRAIN. THE LATTER RESULTS WERE PRESENTED AT THE 2018 ANNUAL MEETING OF THE AMERICAN ACADEMY OF NEUROLOGY.
PUBLIC EDUCATION: RESEARCH CONDUCTED AT CNS HAS BEEN PRESENTED PUBLICALLY AT MEDICAL AND SCIENTIFIC MEETINGS AND PUBLISHED IN LEADING SCIENTIFIC JOURNALS. THESE ACTIVITIES HAVE BEEN REPORTED UPON IN LOCAL AND NATIONAL MEDIA, INCLUDING NBC AND CNN TELEVISION, THE SAN DIEGO UNION TRIBUNE, THE LOS ANGELES AND NEW YORK TIMES AND SCIENTIFIC AMERICAN. CNS ALSO PROVIDES INFORMATION ABOUT NEUROLOGICAL DISEASES TO PATIENTS, PHYSICIANS AND THE GENERAL PUBLIC VIA IT'S WEBSITE (CNSONLINE.ORG). ADDITIONALY CNS IS INVOLVED IN ORGANIZING AN ANNUAL CONFERENCE ON AMYOTROPHIC LATERAL SCLEROSIS IN COLLABORATION WITH ACADEMIC INSTITUTUIONS IN CALIFORNIA (CALIFORNIA ALS SUMMIT).
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Richard A Smith MD President | OfficerTrustee | 40 | $100,000 |
Kathleen Myers Secretary/treas | OfficerTrustee | 8 | $48,000 |
Steve Bordner Director | Trustee | 0.1 | $0 |
Daryl Smith Director | Trustee | 0.1 | $0 |
David Louis Cutchin PHD Director | Trustee | 0.1 | $0 |
Randall Kaye MD Director | Trustee | 0.1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $44 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $44 |
Total Program Service Revenue | $0 |
Investment income | $442,759 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $50,000 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $1,495,487 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $1,988,290 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $75,000 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $148,000 |
Compensation of current officers, directors, key employees. | $29,600 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $12,034 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $12,615 |
Fees for services: Management | $0 |
Fees for services: Legal | $4,126 |
Fees for services: Accounting | $4,525 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $151,816 |
Fees for services: Other | $49,541 |
Advertising and promotion | $0 |
Office expenses | $1,541 |
Information technology | $2,302 |
Royalties | $25,000 |
Occupancy | $28,522 |
Travel | $140 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $40 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $377 |
Insurance | $5,632 |
All other expenses | $370 |
Total functional expenses | $531,222 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $316,108 |
Savings and temporary cash investments | $35,051 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $3,568 |
Investments—publicly traded securities | $26,984,241 |
Investments—other securities | $456,063 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $1,900 |
Total assets | $27,796,931 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $573 |
Total liabilities | $573 |
Net assets without donor restrictions | $27,796,358 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $27,796,931 |
Over the last fiscal year, Center For Neurologic Study has awarded $65,000 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
La Jolla, CA PURPOSE: SUPPORT ALS /JOHN RAVIT'S RESEARCH | $50,000 |
Woodland Hills, CA PURPOSE: SUPPORT ALS RESEARCH | $15,000 |
Over the last fiscal year, we have identified 1 grants that Center For Neurologic Study has recieved totaling $63.
Awarding Organization | Amount |
---|---|
Amazonsmile Foundation Seattle, WA PURPOSE: GENERAL SUPPORT | $63 |
Organization Name | Assets | Revenue |
---|---|---|
Options Family Of Services San Luis Obispo, CA | $11,488,253 | $8,167,771 |
The Childrens Center For Neurodevelopmental Studies Inc Glendale, AZ | $2,775,560 | $3,799,322 |
High Hopes Neurological Recovery Group Inc Tustin, CA | $3,161,830 | $1,419,996 |
International Society For Neurochemistry Inc Encino, CA | $30,086,871 | $5,047,047 |
Center For Neurologic Study La Jolla, CA | $27,796,931 | $1,988,290 |
Ed Ahead Tucson, AZ | $352,867 | $511,947 |
Not Impossible Foundation Inc Venice, CA | $764,169 | $611,708 |
Shirley & Stefan Hatos Neuroscience Research Foundation Los Angeles, CA | $3,731,161 | $211,761 |
Kurt Peter Foundation Menlo Park, CA | $1,371,517 | $128,942 |
Center For Neurological Reprogramming Inc Santa Rosa, CA | $158,761 | $0 |
Brain Society Of California Woodland Hills, CA | $84,334 | $0 |
Rock Steady Boxing Mesa Nfp Mesa, AZ | $3,556 | $0 |